The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer.
 
William S. Chen
No Relationships to Disclose
 
Rahul Raj Aggarwal
Consulting or Advisory Role - AstraZeneca
Research Funding - Abbvie; Cancer Targeted Technology; Gilead Sciences; Janssen; Merck; Novartis; Xynomic Pharma; Zenith Epigenetics
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis; Unity Biotechnology
Travel, Accommodations, Expenses - Dendreon
 
Shuang Zhao
No Relationships to Disclose
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Clovis Oncology; Janssen; Janssen Biotech; Merck; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Medarex (Inst); Janssen Research & Development (Inst); Medivation/Astellas (Inst); Oncogenex (Inst); Sotio; Sotio (Inst); Theraclone Sciences (Inst)
 
David A Quigley
No Relationships to Disclose
 
Adam Foye
No Relationships to Disclose
 
Denise Playdle
No Relationships to Disclose
 
Paul Lloyd
No Relationships to Disclose
 
Matthew Rettig
No Relationships to Disclose
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Christopher P. Evans
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Janssen Oncology; Medivation; Millennium
Speakers' Bureau - Janssen Oncology; Medivation; Sanofi
Research Funding - Medivation
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Medivation; Sanofi
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; CellMax Life; Exelixis; Foundation Medicine; Genentech/Roche; Janssen; Merck; Nektar; Pfizer; Turnstone Bio
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Incyte (Inst); Janssen Biotech (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Polaris (Inst); TRACON Pharma (Inst)
 
Vishal Kothari
No Relationships to Disclose
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Robert Evan Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Genomic Health; ImaginAb; Janssen Oncology
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Christopher Maher
No Relationships to Disclose
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Dendreon; EMD Serono; Ferring; Janssen Oncology; Sanofi
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Fortis; Janssen Oncology
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
Joshi J. Alumkal
Consulting or Advisory Role - Janssen Biotech
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Gilead Sciences (Inst); Novartis (Inst); Zenith Epigenetics (Inst)